Pharmaceuticals
10 Eli Lilly executives
These ten Eli Lilly executives have held chair and CEO, executive vice president, chief scientific, chief medical, chief procurement and business unit president roles at Eli Lilly and Company. Readers can learn how Eli Lilly leaders run research and development, global manufacturing, procurement, finance and its cardiometabolic, international, neuroscience and oncology businesses.
Professionals to explore
01—10Carole Ho
LinkedInExperience: Incoming President Lilly Neuroscience · Eli Lilly and Company
Incoming President Lilly Neuroscience at Eli Lilly and Company since December 2025; the profile headline gives the title Executive Vice President and President, Lilly Neuroscience. Former Chief Medical Officer and Head of Development at Denali Therapeutics (2015–2025). Board member at Royalty Pharma since 2025 and Beam Therapeutics since 2018.
Daniel Skovronsky
LinkedInExperience: Executive Vice President and Chief Scientific and Product Officer · Eli Lilly and Company
Executive Vice President and Chief Scientific and Product Officer at Eli Lilly and Company since November 2025, also described as president of Lilly Research Laboratories overseeing global business development. Former Executive Vice President and Chief Scientific Officer (2018–2025) and Senior Vice President, Clinical and Product Development (2014–2018), and founder and CEO of Avid Radiopharmaceuticals (2005–2012).
Dave Ricks
LinkedInExperience: Chair, CEO · Eli Lilly and Company
Chair, CEO of Eli Lilly and Company since 2017, and a board member at Adobe per the profile. Former President, Lilly Bio-Medicines (2012–2016), President, Lilly USA (2010–2012), President and General Manager, Lilly China (2008–2010) and General Manager, Lilly Canada (2005–2008) at Eli Lilly and Company.
David Hyman
LinkedInExperience: Chief Medical Officer, Eli Lilly and Company · Eli Lilly and Company
Chief Medical Officer, Eli Lilly and Company since October 2023, working with the CSO, therapeutic area development leaders and business development, and also Chief Medical Officer of Loxo@Lilly since 2020, where the profile describes directly leading oncology development. Former Chief, Early Drug Development at Memorial Sloan Kettering Cancer Center (2017–2019).
Edgardo Hernandez
LinkedInExperience: President, Global Manufacturing · Eli Lilly and Company
President, Global Manufacturing at Eli Lilly and Company since May 2021, listed at the President/Vice President level. The profile also lists Sr. Vice President, Drug Product Manufacturing from 2018. Former Vice President of Manufacturing (2016–2018), Site Head, Indianapolis API (2013–2016) and Site Head, PR06, Small Molecule API (2011–2012) at Eli Lilly and Company.
Kenneth L. Custer
LinkedInExperience: Executive Vice President and President, Cardiometabolic Health · Eli Lilly and Company
Executive Vice President and President, Cardiometabolic Health at Eli Lilly and Company since June 2025, leading work across diabetes, obesity-related conditions and cardiovascular disease. Former President and General Manager of Lilly Canada (2023–2025), Senior Vice President and Head of Corporate Business Development (2020–2023) and Vice President, Portfolio Strategy and Chief of Staff, Lilly Research Labs (2018–2020).
Mark Stempel
LinkedInExperience: Sr. Vice President - CFO Lilly USA · Eli Lilly and Company
Sr. Vice President - CFO Lilly USA at Eli Lilly and Company since June 2025. Former Sr. Vice President - CFO Lilly Diabetes & Obesity and Lilly USA (2024–2025), Vice President, CFO Lilly Diabetes & Obesity Business Unit (2023–2024), Associate Vice President, CFO Lilly Diabetes Business Unit (2021–2023) and Sr. Director, Corporate Financial Planning and Global Services (2018–2021).
Patrik Jonsson
LinkedInExperience: Executive Vice President President, Lilly International · Eli Lilly and Company
Executive Vice President and President, Lilly International since July 2025. Former Executive Vice President and President, Lilly Cardiometabolic Health and Lilly USA (2024–2025), President, Lilly Immunology, Lilly USA and Chief Customer Officer (2021–2024) and Senior Vice President, President, Lilly Bio-Medicines (2019–2020). The profile says the Lilly career began in 1990 as a sales representative.
Sherry Davis
LinkedInExperience: Senior Vice President, Chief Procurement Officer · Eli Lilly and Company
Senior Vice President, Chief Procurement Officer at Eli Lilly and Company since March 2024. Former CFO, Lilly USA (2018–2024), including Vice President, CFO, Lilly USA and Immunology (2021–2024). The profile says the Lilly career began in 2006 as a financial consultant with Lilly Research Laboratories and included an assignment in Johannesburg, South Africa.
Sue Mahony
LinkedInExperience: President Lilly Oncology · Eli Lilly and Company
Former President Lilly Oncology at Eli Lilly and Company (2011–2018), described as leading Lilly's global oncology business, and former Senior Vice President Human Resources and Diversity at Eli Lilly and Company (2009–2011). Now a lead independent director and compensation committee chair on several healthcare boards, and co-founder of B&M Impact Foundation since 2018.
Choose the right perspective
Match the executive's business unit or function to your question, since a research or medical leader sees different decisions than a manufacturing, procurement or commercial leader. Check each role's dates to confirm whether the experience you need is current or from an earlier period.
Questions to take into the conversation
- 01How does Eli Lilly decide which research programs and acquisitions to fund?
- 02What do Eli Lilly manufacturing and procurement leaders look for when adding capacity or choosing a new supplier?
- 03How does a large drug maker plan the launch of a new medicine across the United States and international markets?
Reaching Eli Lilly executives
How can I contact one of these Eli Lilly executives?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Eli Lilly and Company, based on profile data retrieved on October 8, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Eli Lilly executives?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal